longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Jefferies Reaffirms Their Buy Rating on Abbott Laboratories (ABT)

Tip Ranks
Jul 17, 2026 at 01:35 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Jefferies reaffirmed a Buy rating on Abbott Laboratories (ABT) with a $135 price target. Additionally, Citi maintained a Buy rating on the stock with a $112 price target.

Jefferies analyst reiterated a Buy rating on Abbott Laboratories today and set a price target of $135.00.

TipRanks Welcomes a New ETF – NYSE:RANK

  • TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
  • RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

In a report released today, Citi also maintained a Buy rating on the stock with a $112.00 price target.

Login to unlock29characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Abbott Laboratories

Abbott Laboratories

USABT

+0.80%

Jefferies Financial

Jefferies Financial

USJEF

Citigroup

Citigroup

USC

LongbridgeAI